These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26319067)

  • 1. Heterosubtypic immunity to H7N9 influenza virus in isogenic guinea pigs after infection with pandemic H1N1 virus.
    Wiersma LC; Vogelzang-van Trierum SE; Kreijtz JH; van Amerongen G; van Run P; Ladwig M; Banneke S; Schaefer H; Fouchier RA; Kuiken T; Osterhaus AD; Rimmelzwaan GF
    Vaccine; 2015 Dec; 33(49):6977-82. PubMed ID: 26319067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus replication kinetics and pathogenesis of infection with H7N9 influenza virus in isogenic guinea pigs upon intratracheal inoculation.
    Wiersma LC; Kreijtz JH; Vogelzang-van Trierum SE; van Amerongen G; van Run P; Ladwig M; Banneke S; Schaefer H; Fouchier RA; Kuiken T; Osterhaus AD; Rimmelzwaan GF
    Vaccine; 2015 Dec; 33(49):6983-7. PubMed ID: 26307235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of infection with 2009 pandemic H1N1 influenza virus in isogenic guinea pigs after intranasal or intratracheal inoculation.
    Wiersma LC; Vogelzang-van Trierum SE; van Amerongen G; van Run P; Nieuwkoop NJ; Ladwig M; Banneke S; Schaefer H; Kuiken T; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    Am J Pathol; 2015 Mar; 185(3):643-50. PubMed ID: 25555619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
    Van Reeth K; Braeckmans D; Cox E; Van Borm S; van den Berg T; Goddeeris B; De Vleeschauwer A
    Vaccine; 2009 Oct; 27(45):6330-9. PubMed ID: 19840669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suboptimal Humoral Immune Response against Influenza A(H7N9) Virus Is Related to Its Internal Genes.
    Lee AC; Zhu H; Zhang AJ; Li C; Wang P; Li C; Chen H; Hung IF; To KK; Yuen KY
    Clin Vaccine Immunol; 2015 Dec; 22(12):1235-43. PubMed ID: 26446420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-protection against European swine influenza viruses in the context of infection immunity against the 2009 pandemic H1N1 virus: studies in the pig model of influenza.
    Qiu Y; De Hert K; Van Reeth K
    Vet Res; 2015 Sep; 46():105. PubMed ID: 26404790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies of influenza A(H1N1)pdm09 virus in pigs' sera cross-react with other influenza A virus subtypes. A retrospective epidemiological interpretation of Norway's serosurveillance data from 2009-2017.
    Er JC; Lium B; Framstad T
    Epidemiol Infect; 2020 Mar; 148():e73. PubMed ID: 32167441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and subsequent cross-protection of influenza virus infection in pigs sustained by an H1N2 strain.
    Ferrari M; Borghetti P; Foni E; Robotti C; Di Lecce R; Corradi A; Petrini S; Bottarelli E
    Zoonoses Public Health; 2010 Jun; 57(4):273-80. PubMed ID: 19538454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.
    Xu J; Yang D; Huang D; Xu J; Liu S; Lin H; Zhu H; Liu B; Lu C
    Arch Virol; 2013 Mar; 158(3):629-37. PubMed ID: 23135159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemagglutinin 222D/G polymorphism facilitates fast intra-host evolution of pandemic (H1N1) 2009 influenza A viruses.
    Seidel N; Sauerbrei A; Wutzler P; Schmidtke M
    PLoS One; 2014; 9(8):e104233. PubMed ID: 25162520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine-associated enhanced respiratory disease does not interfere with the adaptive immune response following challenge with pandemic A/H1N1 2009.
    Gauger PC; Loving CL; Lager KM; Janke BH; Kehrli ME; Roth JA; Vincent AL
    Viral Immunol; 2013 Oct; 26(5):314-21. PubMed ID: 24033080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs.
    Wodal W; Schwendinger MG; Savidis-Dacho H; Crowe BA; Hohenadl C; Fritz R; Brühl P; Portsmouth D; Karner-Pichl A; Balta D; Grillberger L; Kistner O; Barrett PN; Howard MK
    PLoS One; 2015; 10(2):e0113963. PubMed ID: 25719901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza A virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs.
    Rajão DS; Loving CL; Gauger PC; Kitikoon P; Vincent AL
    Vaccine; 2014 Sep; 32(40):5170-6. PubMed ID: 25077416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-immunity Against Avian Influenza A(H7N9) Virus in the Healthy Population Is Affected by Antigenicity-Dependent Substitutions.
    Liu WJ; Tan S; Zhao M; Quan C; Bi Y; Wu Y; Zhang S; Zhang H; Xiao H; Qi J; Yan J; Liu W; Yu H; Shu Y; Wu G; Gao GF
    J Infect Dis; 2016 Dec; 214(12):1937-1946. PubMed ID: 27738054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virus A/Anhui/1/2013 (H7N9) replicates efficiently in the upper and lower respiratory tracts of cynomolgus macaques.
    de Wit E; Rasmussen AL; Feldmann F; Bushmaker T; Martellaro C; Haddock E; Okumura A; Proll SC; Chang J; Gardner D; Katze MG; Munster VJ; Feldmann H
    mBio; 2014 Aug; 5(4):. PubMed ID: 25118237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H7N9 Influenza Virus Is More Virulent in Ferrets than 2009 Pandemic H1N1 Influenza Virus.
    Yum J; Ku KB; Kim HS; Seo SH
    Viral Immunol; 2015 Dec; 28(10):590-9. PubMed ID: 26421365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets.
    Maltais AK; Stittelaar KJ; Veldhuis Kroeze EJ; van Amerongen G; Dijkshoorn ML; Krestin GP; Hinkula J; Arwidsson H; Lindberg A; Osterhaus AD
    Vaccine; 2014 May; 32(26):3307-15. PubMed ID: 24690149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.
    Leung HC; Chan CC; Poon VK; Zhao HJ; Cheung CY; Ng F; Huang JD; Zheng BJ
    Emerg Microbes Infect; 2015 Apr; 4(4):e22. PubMed ID: 26038770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An elastase-dependent attenuated heterologous swine influenza virus protects against pandemic H1N1 2009 influenza challenge in swine.
    Babiuk S; Masic A; Graham J; Neufeld J; van der Loop M; Copps J; Berhane Y; Pasick J; Potter A; Babiuk LA; Weingartl H; Zhou Y
    Vaccine; 2011 Apr; 29(17):3118-23. PubMed ID: 21382482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.